Results indicate GE1111’s effects on MRGPRX2 inhibition, which contributes to anti-pruritic outcomes; alternative itch models (e.g., acute/chronic) could further validate broad anti-itching efficacy [51]. The gene discussed is MRGPRX2; the disease is Pruritus.